Primary Category:
Treatment Protocols
Disease Category:
Multiple Myeloma
Status:
Open
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Eligible for screening study DCP 001
NCT#03937635
Primary Category:
Treatment Protocols
Disease Category:
Multiple Myeloma
Status:
Open
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Eligible for screening study DCP 001
NCT#03937635